eF-site ID 6c4j-L
PDB Code 6c4j
Chain L

click to enlarge
Title Ligand bound full length hUGDH with A104L substitution
Classification OXIDOREDUCTASE
Compound UDP-glucose 6-dehydrogenase
Source (UGDH_HUMAN)
Sequence L:  MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNES
RINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIK
EADLVFISVNTPTKTYGMGKGRALDLKYIEACARRIVQNS
NGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNP
EFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYE
HWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISAL
CEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKD
VLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIID
SLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDE
GAHLHIYDPKVPREQIVVDLSHDQVSRLVTISKDPYEACD
GAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLD
GLHNELQTIGFQIETIGKKV
Description


Functional site

1) chain L
residue 260
type
sequence R
description binding site for residue UPG K 502
source : AG6

2) chain L
residue 260
type
sequence R
description binding site for residue PGO K 506
source : AH1

3) chain L
residue 10
type
sequence I
description binding site for residue NAD L 501
source : AH2

4) chain L
residue 11
type
sequence G
description binding site for residue NAD L 501
source : AH2

5) chain L
residue 13
type
sequence G
description binding site for residue NAD L 501
source : AH2

6) chain L
residue 14
type
sequence Y
description binding site for residue NAD L 501
source : AH2

7) chain L
residue 15
type
sequence V
description binding site for residue NAD L 501
source : AH2

8) chain L
residue 36
type
sequence D
description binding site for residue NAD L 501
source : AH2

9) chain L
residue 41
type
sequence R
description binding site for residue NAD L 501
source : AH2

10) chain L
residue 88
type
sequence S
description binding site for residue NAD L 501
source : AH2

11) chain L
residue 89
type
sequence V
description binding site for residue NAD L 501
source : AH2

12) chain L
residue 91
type
sequence T
description binding site for residue NAD L 501
source : AH2

13) chain L
residue 108
type
sequence Y
description binding site for residue NAD L 501
source : AH2

14) chain L
residue 130
type
sequence S
description binding site for residue NAD L 501
source : AH2

15) chain L
residue 131
type
sequence T
description binding site for residue NAD L 501
source : AH2

16) chain L
residue 161
type
sequence E
description binding site for residue NAD L 501
source : AH2

17) chain L
residue 279
type
sequence K
description binding site for residue NAD L 501
source : AH2

18) chain L
residue 162
type
sequence F
description binding site for residue UPG L 502
source : AH3

19) chain L
residue 163
type
sequence L
description binding site for residue UPG L 502
source : AH3

20) chain L
residue 164
type
sequence A
description binding site for residue UPG L 502
source : AH3

21) chain L
residue 165
type
sequence E
description binding site for residue UPG L 502
source : AH3

22) chain L
residue 220
type
sequence K
description binding site for residue UPG L 502
source : AH3

23) chain L
residue 224
type
sequence N
description binding site for residue UPG L 502
source : AH3

24) chain L
residue 231
type
sequence I
description binding site for residue UPG L 502
source : AH3

25) chain L
residue 265
type
sequence F
description binding site for residue UPG L 502
source : AH3

26) chain L
residue 266
type
sequence L
description binding site for residue UPG L 502
source : AH3

27) chain L
residue 267
type
sequence K
description binding site for residue UPG L 502
source : AH3

28) chain L
residue 269
type
sequence S
description binding site for residue UPG L 502
source : AH3

29) chain L
residue 272
type
sequence F
description binding site for residue UPG L 502
source : AH3

30) chain L
residue 273
type
sequence G
description binding site for residue UPG L 502
source : AH3

31) chain L
residue 276
type
sequence C
description binding site for residue UPG L 502
source : AH3

32) chain L
residue 277
type
sequence F
description binding site for residue UPG L 502
source : AH3

33) chain L
residue 338
type
sequence F
description binding site for residue UPG L 502
source : AH3

34) chain L
residue 339
type
sequence K
description binding site for residue UPG L 502
source : AH3

35) chain L
residue 442
type
sequence R
description binding site for residue UPG L 502
source : AH3

36) chain L
residue 135
type
sequence R
description binding site for residue CL L 503
source : AH4

37) chain L
residue 99
type
sequence G
description binding site for residue CL L 504
source : AH5

38) chain L
residue 162
type
sequence F
description binding site for residue PGO L 505
source : AH6

39) chain L
residue 171
type
sequence D
description binding site for residue PGO L 505
source : AH6

40) chain L
residue 176
type
sequence D
description binding site for residue PGO L 505
source : AH6

41) chain L
residue 161
type ACT_SITE
sequence E
description Proton donor/acceptor => ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI1

42) chain L
residue 220
type ACT_SITE
sequence K
description Proton donor/acceptor => ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI1

43) chain L
residue 276
type ACT_SITE
sequence C
description Nucleophile => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21984906, ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI2

44) chain L
residue 11
type BINDING
sequence G
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

45) chain L
residue 36
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

46) chain L
residue 41
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

47) chain L
residue 89
type BINDING
sequence V
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

48) chain L
residue 276
type BINDING
sequence C
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

49) chain L
residue 130
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445
source Swiss-Prot : SWS_FT_FI4

50) chain L
residue 161
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

51) chain L
residue 220
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

52) chain L
residue 267
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

53) chain L
residue 338
type BINDING
sequence F
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

54) chain L
residue 165
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:21502315, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4
source Swiss-Prot : SWS_FT_FI6

55) chain L
residue 107
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI10

56) chain L
residue 260
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000269|PubMed:27966912, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF, ECO:0007744|PDB:5TJH
source Swiss-Prot : SWS_FT_FI7

57) chain L
residue 346
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0000269|PubMed:22123821, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI8

58) chain L
residue 442
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:22123821, ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3KHU, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI9


Display surface

Download
Links